Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon 1649-003, Portugal.
Biochem Biophys Res Commun. 2010 Oct 1;400(4):649-54. doi: 10.1016/j.bbrc.2010.08.121. Epub 2010 Aug 31.
p53/Mdm-2 interaction is a prime target of ursodeoxycholic acid (UDCA) for regulating apoptosis in primary rat hepatocytes. Here, we further explored the role of UDCA in downregulating p53 by Mdm-2. UDCA reduced the stability of p53 by decreasing protein half-life. Although proteasomal activity was slightly increased with UDCA, the effect was also observed for other bile acids. More importantly, immunoprecipitation assays revealed that UDCA promoted p53 ubiquitination, therefore leading to increased p53 degradation. In this regard, proteasome inhibition after UDCA pre-treatment resulted in accumulation of ubiquitinated p53, which in turn was prevented in cells overexpressing a mutated form of p53 that does not undergo Mdm-2 ubiquitination. The involvement of Mdm-2 in UDCA-mediated response was further confirmed by siRNA-mediated gene silencing experiments. Finally, the protective effect of UDCA against p53-induced apoptosis was abolished after inhibition of proteasome activity and prevention of p53 ubiquitination by Mdm-2. These findings suggest that UDCA protects cells from p53-mediated apoptosis by promoting its degradation via the Mdm-2-ubiquitin-proteasome pathway.
p53/Mdm-2 相互作用是熊去氧胆酸(UDCA)调节原代大鼠肝细胞凋亡的主要靶点。在这里,我们进一步探讨了 UDCA 通过 Mdm-2 下调 p53 的作用。UDCA 通过降低蛋白质半衰期来减少 p53 的稳定性。尽管 UDCA 略微增加了蛋白酶体的活性,但其他胆酸也观察到了这种作用。更重要的是,免疫沉淀试验表明,UDCA 促进了 p53 的泛素化,从而导致 p53 降解增加。在这方面,UDCA 预处理后蛋白酶体抑制导致泛素化 p53 的积累,而在过表达不经历 Mdm-2 泛素化的突变型 p53 的细胞中则防止了这种积累。通过 siRNA 介导的基因沉默实验进一步证实了 Mdm-2 在 UDCA 介导的反应中的参与。最后,蛋白酶体活性抑制和 Mdm-2 阻止 p53 泛素化后,UDCA 对 p53 诱导的细胞凋亡的保护作用被消除。这些发现表明,UDCA 通过 Mdm-2-泛素-蛋白酶体途径促进其降解,从而保护细胞免受 p53 介导的凋亡。